BrainsWay Ltd. – NASDAQ:BWAY

BrainsWay Ltd. stock price today

$14.32
+5.18
+56.85%
Financial Health
0
1
2
3
4
5
6
7
8
9

BrainsWay Ltd. stock price monthly change

+39.18%
month

BrainsWay Ltd. stock price quarterly change

+39.18%
quarter

BrainsWay Ltd. stock price yearly change

+40.25%
year

BrainsWay Ltd. key metrics

Market Cap
171.57M
Enterprise value
N/A
P/E
-2.2
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
0.98
Price/Book
0.59
PEG ratio
0.02
EPS
-0.09
Revenue
34.25M
EBITDA
129K
Income
-1.65M
Revenue Q/Q
37.28%
Revenue Y/Y
32.60%
Profit margin
-48.26%
Oper. margin
-45.6%
Gross margin
73.62%
EBIT margin
-45.6%
EBITDA margin
0.38%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

BrainsWay Ltd. stock price history

BrainsWay Ltd. stock forecast

BrainsWay Ltd. financial statements

BrainsWay Ltd. (NASDAQ:BWAY): Profit margin
Jun 2023 7.82M -1.66M -21.24%
Sep 2023 8.30M -230K -2.77%
Dec 2023 9.02M 127K 1.41%
Mar 2024 9.09M 111K 1.22%
BrainsWay Ltd. (NASDAQ:BWAY): Analyst Estimates
Dec 2023 9.02M 127K 1.41%
Mar 2024 9.09M 111K 1.22%
Sep 2025 11.45M 415.92K 3.63%
Dec 2025 12.05M 582.29K 4.83%
  • Analysts Price target

  • Financials & Ratios estimates

BrainsWay Ltd. (NASDAQ:BWAY): Earnings per share (EPS)
2022-11-18 -0.06 -0.15
2023-03-15 -0.42667 -0.24
BrainsWay Ltd. (NASDAQ:BWAY): Debt to assets
Jun 2023 59247000 17.89M 30.2%
Sep 2023 59774000 18.55M 31.04%
Dec 2023 62972000 15.31M 24.32%
Mar 2024 65143000 17.30M 26.56%
BrainsWay Ltd. (NASDAQ:BWAY): Cash Flow
Jun 2023 995K -1.51M -377K
Sep 2023 1.35M -506K -56K
Dec 2023 2.47M -35.45M -527K
Mar 2024 3.17M -709.99K -589K

BrainsWay Ltd. alternative data

BrainsWay Ltd. (NASDAQ:BWAY): Employee count
Aug 2023 134
Sep 2023 134
Oct 2023 134
Nov 2023 134
Dec 2023 134
Jan 2024 134
Feb 2024 134
Mar 2024 134
Apr 2024 134
May 2024 134
Jun 2024 134
Jul 2024 134

BrainsWay Ltd. other data

5.71% -11.19%
of BWAY is owned by hedge funds
1.88M -3.38M
shares is hold by hedge funds
Patent
Grant
Filling date: 2 Jul 2019 Issue date: 8 Feb 2022
Grant
Filling date: 5 Feb 2019 Issue date: 28 Dec 2021
Application
Filling date: 30 Apr 2019 Issue date: 25 Nov 2021
Application
Filling date: 5 Feb 2019 Issue date: 15 Apr 2021
Grant
Filling date: 30 Oct 2017 Issue date: 21 Apr 2020
Grant
Filling date: 18 Jan 2018 Issue date: 17 Mar 2020
Application
Filling date: 2 Jul 2019 Issue date: 26 Dec 2019
Application
Filling date: 25 Oct 2017 Issue date: 15 Aug 2019
Insider Compensation
Dr. Christopher R. von Jako Ph.D. (1969) Pres & Chief Executive Officer
$463,750
Mr. Hadar Levy (1974) Senior Vice President & GM of North America
$354,000
Mr. Christopher J. Boyer Ph.D. (1978) Vice President of Global Marketing
$146,670
Thursday, 12 December 2024
globenewswire.com
Wednesday, 20 November 2024
globenewswire.com
Tuesday, 12 November 2024
seekingalpha.com
globenewswire.com
Wednesday, 6 November 2024
zacks.com
Thursday, 31 October 2024
zacks.com
Tuesday, 29 October 2024
globenewswire.com
Monday, 21 October 2024
zacks.com
zacks.com
zacks.com
Tuesday, 15 October 2024
zacks.com
Wednesday, 9 October 2024
globenewswire.com
Friday, 4 October 2024
zacks.com
zacks.com
zacks.com
Tuesday, 1 October 2024
zacks.com
Monday, 30 September 2024
globenewswire.com
Wednesday, 18 September 2024
zacks.com
zacks.com
Monday, 16 September 2024
globenewswire.com
Tuesday, 10 September 2024
globenewswire.com
Monday, 9 September 2024
zacks.com
Monday, 2 September 2024
zacks.com
Friday, 30 August 2024
zacks.com
Thursday, 29 August 2024
globenewswire.com
Tuesday, 27 August 2024
zacks.com
Monday, 26 August 2024
zacks.com
zacks.com
Tuesday, 20 August 2024
zacks.com
Monday, 19 August 2024
zacks.com
  • What's the price of BrainsWay Ltd. stock today?

    One share of BrainsWay Ltd. stock can currently be purchased for approximately $14.32.

  • When is BrainsWay Ltd.'s next earnings date?

    Unfortunately, BrainsWay Ltd.'s (BWAY) next earnings date is currently unknown.

  • Does BrainsWay Ltd. pay dividends?

    No, BrainsWay Ltd. does not pay dividends.

  • How much money does BrainsWay Ltd. make?

    BrainsWay Ltd. has a market capitalization of 171.57M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 16.96% to 31.79M US dollars. BrainsWay Ltd. made a loss 4.2M US dollars in net income (profit) last year or -$0.24 on an earnings per share basis.

  • What is BrainsWay Ltd.'s stock symbol?

    BrainsWay Ltd. is traded on the NASDAQ under the ticker symbol "BWAY".

  • What is BrainsWay Ltd.'s primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of BrainsWay Ltd.?

    Shares of BrainsWay Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are BrainsWay Ltd.'s key executives?

    BrainsWay Ltd.'s management team includes the following people:

    • Dr. Christopher R. von Jako Ph.D. Pres & Chief Executive Officer(age: 56, pay: $463,750)
    • Mr. Hadar Levy Senior Vice President & GM of North America(age: 51, pay: $354,000)
    • Mr. Christopher J. Boyer Ph.D. Vice President of Global Marketing(age: 47, pay: $146,670)
  • How many employees does BrainsWay Ltd. have?

    As Jul 2024, BrainsWay Ltd. employs 134 workers.

  • When BrainsWay Ltd. went public?

    BrainsWay Ltd. is publicly traded company for more then 6 years since IPO on 17 Apr 2019.

  • What is BrainsWay Ltd.'s official website?

    The official website for BrainsWay Ltd. is brainsway.com.

  • How can i contact BrainsWay Ltd.?

    BrainsWay Ltd. can be reached via phone at +972 2 582 4030.

BrainsWay Ltd. company profile:

BrainsWay Ltd.

brainsway.com
Exchange:

NASDAQ

Full time employees:

134

Industry:

Medical - Devices

Sector:

Healthcare

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Bynet Building
Jerusalem, 9777518

CIK: 0001505065
ISIN: US10501L1061
CUSIP: 10501L106